CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

NCT01336478 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Haematological Malignancies
Allogeneic Stem Cell Transplant
CD56+CD3- NK Cells

Interventions

PROCEDURE: Infusion of donor derived ex-vivo selected NK cells to patients after transplant
PROCEDURE: Haematology / Blood chemistry sampling

Sponsor

Imperial College London